title: [Empiric treatment of pyelonephritis].
abstract: The article analyses the most typical clinical situations in empirical treatment of pyelonephritis including situations with comorbid severe diseases: decompensated diabetes mellitus, chronic renal failure, HIV-infection. Choice of antibacterial medicines for empiric treatment of pyelonephritis is based on the results of the latest studies of antibioticoresistance of pyelonephritis pathogens as well as on specific features of pharmacokinetics and pharmacodynamics of antibacterial drugs.
authors.forename: S K
authors.initials: SK
authors.lastname: Iarovoĭ
authors.forename: N L
authors.initials: NL
authors.lastname: Shimanovskiĭ
authors.forename: E N
authors.initials: EN
authors.lastname: Kareva
mesh_terms: D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D048909:Diabetes Complications / Q000188:drug therapy; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy; D011704:Pyelonephritis / Q000150:complications / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents